Cardiology

Protein inhibitor holds promise for heart disease treatment

UC Davis scientists have developed a novel cardiovascular agent which, unlike currently available drugs for heart disease, does not target high blood cholesterol or high blood pressure. The experimental agent inhibits C-reactive ...

Diseases, Conditions, Syndromes

Discovery could speed up heart failure and pneumonia diagnosis

(Medical Xpress)—University of Otago researchers have discovered a potential new tool to help doctors in emergency departments quickly and accurately diagnose patients with heart failure and pneumonia.

Cardiology

Rising cardiovascular incidence after Japanese earthquake 2011

The Japanese earthquake and tsunami of 11 March 2011, which hit the north-east coast of Japan with a magnitude of 9.0 on the Richter scale, was one of the largest ocean-trench earthquakes ever recorded in Japan. The tsunami ...

Cardiology

Aspirin still first-line therapy for unstable angina/NSTEMI

(HealthDay) -- Aspirin is still the first line of therapy for patients with unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and ticagrelor can be used in place of clopidogrel or prasugrel instead of aspirin ...

page 3 from 5